Detalhe da pesquisa
1.
Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA): a randomised, controlled, phase 3 trial.
Lancet Oncol
; 23(8): 1031-1043, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35810754
2.
Zanubrutinib monotherapy for patients with treatment naïve chronic lymphocytic leukemia and 17p deletion.
Haematologica
; 106(9): 2354-2363, 2020 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33054121
3.
Health-related quality-of-life in treatment-naive CLL/SLL patients treated with zanubrutinib versus bendamustine plus rituximab.
Curr Med Res Opin
; : 1-7, 2023 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37752878
4.
Regulation of E2F1-induced apoptosis by the nucleolar protein RRP1B.
J Biol Chem
; 285(9): 6348-63, 2010 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-20040599
5.
Immune-stimulating antibody conjugates elicit robust myeloid activation and durable antitumor immunity.
Nat Cancer
; 2(1): 18-33, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35121890
6.
Osteopontin knockdown suppresses tumorigenicity of human metastatic breast carcinoma, MDA-MB-435.
Clin Exp Metastasis
; 23(2): 123-33, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-16830223
7.
The Colony-Stimulating Factor 3 Receptor T640N Mutation Is Oncogenic, Sensitive to JAK Inhibition, and Mimics T618I.
Clin Cancer Res
; 22(3): 757-64, 2016 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26475333
8.
Characterization of p73 functional domains necessary for transactivation and growth suppression.
Oncogene
; 22(28): 4333-47, 2003 Jul 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-12853970
9.
Postgraduate choices of graduates from medical scientist training programs, 2004-2008.
JAMA
; 302(12): 1271-3, 2009 Sep 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-19773561
10.
Regulation of TopBP1 oligomerization by Akt/PKB for cell survival.
EMBO J
; 25(20): 4795-807, 2006 Oct 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-17006541